AnaptysBio insider files Form 144 to sell 10,231 shares on NASDAQ
Rhea-AI Filing Summary
AnaptysBio, Inc. (ANAB) Form 144 shows an intended sale of 10,231 common shares with an aggregate market value of $200,712.78 to be executed on or about 08/08/2025 through Morgan Stanley Smith Barney on NASDAQ. The filing states these shares were acquired by a stock option exercise on 08/08/2025 with payment in cash. The notice also discloses prior sales by the same person, HOLLINGS C RENTON: 20,925 shares sold 07/02/2025 for $493,189.70 and 3,015 shares sold 06/18/2025 for $72,269.55. The signer represents there is no undisclosed material adverse information.
Positive
- Form 144 filed and details disclosed, including broker, sale date, and aggregate market value, demonstrating regulatory compliance.
- Securities were acquired via stock option exercise with cash payment as explicitly stated in the filing.
Negative
- Insider selling reported: HOLLINGS C RENTON sold 20,925 shares on 07/02/2025 for $493,189.70 and 3,015 shares on 06/18/2025 for $72,269.55.
- Planned sale of 10,231 shares valued at $200,712.78 is scheduled for 08/08/2025, indicating continued insider monetization.
Insights
TL;DR Insider exercised options and plans a modest sale; filing details are disclosed and likely immaterial to capitalization.
The filing documents a stock option exercise that created 10,231 shares, immediately slated for sale via Morgan Stanley Smith Barney on NASDAQ for $200,712.78. Given the reported shares outstanding of 27,996,963, the planned sale represents a very small fraction of total capitalization (approximately 0.037%). The filing also lists two recent sales by the same person on 07/02/2025 and 06/18/2025, showing prior monetization activity. For investors, the item is transparent but not likely market-moving based on size alone.
TL;DR Proper Form 144 disclosure and a signed representation reduce regulatory risk; multiple sales by the same individual warrant attention.
The notice includes required disclosures: acquisition method (stock option exercise), payment method (cash), broker (Morgan Stanley Smith Barney) and an affirmation that no material nonpublic information is known. The form also records recent sales by HOLLINGS C RENTON on 07/02/2025 and 06/18/2025. From a compliance standpoint, the filing appears complete; governance review would note repeated insider sales but the absolute sizes disclosed are modest relative to total shares outstanding.